Bioinformatic analysis and experimental validation confirmed that high SLC12A8 expression was strongly associated with reduced infiltration and functional inhibition of CD8<sup>+</sup> T cells in the tumor microenvironment, particularly in Luminal B breast cancer. This evidence concerns the gene CD8A and breast cancer.